Plasma Levels of TNF- in Sickle Cell Patients Receiving Hydroxyurea

References

• Keidan, A.J., Noguchi, C.T., Player, M., Chalder, S.M. and Stuart, J. (1989) "Erythrocyte heterogeneity in sickle cell disease: effect of deoxygenation on intracellular polymer formation and rheology of sub-populations", Br. J. Haematol. 72, 254–259.
   PubMed Web of Science ®Google Scholar
• Yang, Y.M. and Pace, B. (2001) "Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechan-isms", Pediatr. Pathol. Mol. Med. 20, 87–106.
   PubMed Web of Science ®Google Scholar
• Steinberg, M.H., Barton, E, Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., Varma, M., Ramirez, G., Adler, B., Smith, W., Carlos, T., Ataga, K., DeCastro, L., Bigelow, C., Saunthararajah, Y., Telfer, M., Vichinsky, E., Claster, S., Shurin, S., Bridges, K., Waclawiw, M., Bonds, D. and Tenth, M. (2003) "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment", JANIA 13, 1645–1651.
   Google Scholar
• Nahavandi, M., Wyche, Q.M., Perlin, E., Castro, O. and Tavakkoli, F. (2000) "Nitric oxide metabolites in sickle cell anemia patients after oral administration of hydroxyurea", Hematology 5, 335–339.
   PubMedGoogle Scholar
• Nahavandi, M., Tavakkoli, F., Wyche, M.Q., Perlin, E., Winter, W.P. and Castro, O. (2002) "Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea", Br. J. Haematol. 119, 855–857.
   PubMed Web of Science ®Google Scholar
• Gladwin, M.T., Shelhamer, J.H., Ognibene, F.P., Pease-Fye, M.E., Nichols, J.S., Link, B., Patel, D.B., Jankowski, M.A., Pannell, L.K., Schechter, A.N. and Rodgers, G.P. (2002) "Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease", Br. J. Haematol. 116, 436–444.
   PubMed Web of Science ®Google Scholar
• Huang, J., Hadimani, S.B., Rupon, J.W., Ballas, S.K., Kim-Shapiro, D.B. and King, S.B. (2002) "Iron nitrosyl hemoglobin formation from the reactions of hemoglobin and hydroxy-urea", Biochemistry 41, 2466–2474.
   PubMed Web of Science ®Google Scholar
• Camehn, R. and Rehse, K. (2000) "New NO donors with antithrombotic and vasodilating activities, N-(1-cyanoalkyl)-N-hydroxyureas", Arch. Pharm. (Weinheim) 333, 27–31.
   PubMed Web of Science ®Google Scholar
• Tsuchiya, K., Jiang, J.J., Yoshizumi, M., Tamaki, T., Houchi, H., Minakuchi, K., Fukuzawa, K. and Mason, R.P. (1999) "Nitric oxide-forming reactions of the water-soluble nitric oxide spin-trapping agent, MGD", Free Radic. Biol. Med. 7, 347–355.
   Google Scholar
• Cokie, V.P., Smith, R.D., Beleslin-Cokie, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. and Schechter, A.N. (2003) "Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase", J. Clin. Investig. 11, 231–239.
   Google Scholar
• Deng, W., Thiel, B., Tannenbaum, CS., Hamilton, T.A. and Stuehr, D.J. (1993) "Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages", J. Immunol. 151, 322–329.
   PubMed Web of Science ®Google Scholar
• Schneemarm, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L. and Schaffner, A. (1993) "Nitric oxide synthase is not a constituent of the antimicrobial armature of human mono-nuclear phagocytes", J. Infect. Dis. 167, 1358–1363.
   PubMed Web of Science ®Google Scholar
• Francis, R.B. and Haywood, J. (1992) "Elevated immuno-reactive tumor necrosis factor and interleukin 1 in sickle cell diseases", J. Natl Med. Assoc. 84, 611–615.
   PubMed Web of Science ®Google Scholar
• Malave, I., Pedromo, Y., Escalona, E., et al. (1993) "Levels of tumor necrosis factor alpha /cachectin (TNF-a) in serum from patients with sickle cell diseases", Acta Hematol. 90, 172–176.
   PubMed Web of Science ®Google Scholar
• Brown, M.D., Wick, T.M. and Eckman, J.R. (2001) "Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells", Pediatr. Pathol. Mol. Med. 20, 47–72.
   PubMed Web of Science ®Google Scholar
• Gladwin, M.T., Schechter, A.N., Ognibene, F.P., Coles, W.A., Reiter, C.D., Schenke, W.H., Csako, G., Waclawiw, M.A., Panza, J.A. and Cannon, R.O. III, (2003) "Divergent nitric oxide bioavailability in men and women with sickle cell disease", Circulation 107, 271–278.
   PubMed Web of Science ®Google Scholar
• Space, S.L., Lane, P.A., Pickett, C.K. and Weil, J.V. (2000) "Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium", Am. J. Hematol. 63, 200–204.
   PubMed Web of Science ®Google Scholar
• Setty, B.N., Kulkarni, S., Dampier, C.D. and Stuart, M.J. (2001) "Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion", Blood 97, 2568–2573.
   PubMed Web of Science ®Google Scholar
• Setty, B.N. and Stuart, M.J. (1996) "Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease", Blood 88, 2311–2320.
   PubMed Web of Science ®Google Scholar
• Montes, R.A., Eckman, J.R., Hsu, L.L. and Wick, T.M. (2001) "Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion", Am. J. Hematol. 70, 216–227.
   Web of Science ®Google Scholar
• Pai, K., Shrivastava, A., Kumar, R., Khetarpal, S., Sarmah, B., Gupta, P. and Sodhi, A. (1997) "Activation of P388D1 macrophage cell line by chemotherapeutic drugs", Life Sci. 60, 1239–1248.
   PubMed Web of Science ®Google Scholar
• Pocsik, E., Mihalik, R., Penzes, M., Loetscher, H., Gallati, H. and Aggarwal, B.B. (1995) "Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors", J. Cell. Biochem. 59, 303–316.
   PubMed Web of Science ®Google Scholar
• Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P. and Vercellotti, G.M. (2000) "Activated monocytes in sickle cell disease: potential role in the activation of vascular endo-thelium and vaso-occlusion", Blood 96, 2451–2459.
   PubMed Web of Science ®Google Scholar
• Raghupathy, R., Haidar, M.Z., Aizizeh, T.M., D'Souza, T.M. and Adekile, A.D. (2000) "Tumor necrosis factor is undetectable in the plasma of SS patients with elevated HbF", Am. J. Hematol. 64, 91–94.
   PubMed Web of Science ®Google Scholar